直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Jin Liang, Ph.D.
Technical Specialist
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4325
jin.liang@finnegan.com jin.liang@finnegan.com

Jin Liang, Ph.D.

Technical Specialist

  • +1 202 408 4325 +1 202 408 4325
  • jin.liang@finnegan.com jin.liang@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Jin Liang, Ph.D., applies her extensive expertise in biology, biotechnology, and biomedical science to intellectual property (IP) matters. Her work focuses on patent portfolio management, due diligence, opinions, and client counseling related to a broad range of fields, including biotechnology, biologics, small-molecule therapeutics, and gene therapy.

Jin obtained her doctorate through the Graduate Partnership Program co-hosted by the National Institutes of Health (NIH) and the University of Maryland, where she identified candidate therapeutic targets for hearing loss by transcriptome profiling in zebrafish. Prior to joining Finnegan, she worked as a research associate at Cornell University, where she developed cutting-edge high-throughput technologies to characterize the functional impacts of variants in the human genome. Jin also gained technology transfer experience at the Cornell Center for Technology Licensing (CTL).

 

Et Cetera

  • Co-first author. “Transcription imparts architecture, function and logic to enhancer units,” Nature Genetics, 2020.

  • Coauthor. “A massively parallel barcoded sequencing pipeline enables generation of the first ORFeome and interactome map for rice,” Proceedings of the National Academy of Sciences of the United States of America, 2020.

  • Coauthor. “MaXLinker: Proteome-wide cross-link identifications with high specificity and sensitivity,” Molecular & Cellular Proteomics, 2020.

  • Coauthor. “Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations,” Nature Communications, 2019.

  • Coauthor. “GRAM: A generalized model to predict the molecular effect of a non-coding variant in a cell-type specific manner,” PLOS Genetics, 2019.

  • Coauthor. “Interactome INSIDER: a structural interactome browser for genomic studies,” Nature Methods, 2018.

  • Co-first author. “A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations,” PLOS Genetics, 2014.

  • Coauthor. “Elucidating common structural features of human pathogenic variations using large-scale atomic-resolution protein networks,” Human Mutation, 2014.

  • First author. “The stat3/socs3a pathway is a key regulator of hair cell regeneration in zebrafish,” Journal of Neuroscience, 2012.

  • First author. “Sequencing-based expression profiling in zebrafish,” Methods in Cell Biology, 2011.

Admissions and Education

Education

Georgetown University Law Center
J.D., expected 2028
University of Maryland
Ph.D., Neuroscience and Cognitive Science, 2010
Ocean University of China
B.S., Biotechnology, 2002

Languages

  • Chinese (Cantonese and Mandarin)

Jin's Practices

Diligence, Licensing, and Opinions
Due Diligence
Prosecution and Portfolio Management
IP Portfolio Management
Opinions and Counseling

Jin's Industries

Communications
Financial Services and Business Systems
Consumer Goods and Services
Consumer Products
Life Sciences
Biologics
Biotechnology
Digital Health
Medical Device and Diagnostics
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP